A. Kawabata et al., EFFECT OF TOPICAL ADMINISTRATION OF L-ARGININE ON FORMALIN-INDUCED NOCICEPTION IN THE MOUSE - A DUAL ROLE OF PERIPHERALLY FORMED NO IN PAINMODULATION, British Journal of Pharmacology, 112(2), 1994, pp. 547-550
1 We investigated the effects of intraplantar (i.pl.) administration o
f L-arginine and NG-nitro-L-arginine methyl eater (L-NAME) on formalin
-induced behavioural nociception in the mouse. 2 L- but not D-arginine
, at 0.1-1 mu g per paw, coadministered with i.pl. formalin, enhanced
the second- but not the first-phase nociceptive responses, whereas it
was without significant effects at 3 mu g per paw, and conversely, pro
duced antinociception at 10 mu g per paw, resulting in a bell-shaped d
ose-response curve. 3 L-NAME at 0.1-1 mu g per paw, when administered
i.pl., exhibited antinociceptive activity in the second phase in a dos
e-dependent manner, although its D-enantiomer produced no effect. 4 An
antinociceptive dose (I mu g per paw) of L-NAME (i.pl.) considerably
reduced the increase in second-phase nociception elicited by low doses
(1 mu g per paw) of i.pl. L-arginine. The second-phase nociception de
crease induced by a large dose (10 mu g per paw) of i.pl. L-arginine w
as markedly reversed by i.pl. L-NAME at 0.1 mu g per paw, raising it t
o a level above that of the control (formalin only). 5 These results s
uggest that peripheral NO plays a dual role in nociceptive modulation,
depending on the tissue level, inducing either nociceptive or antinoc
iceptive responses.